Burosumab-twza Subcutaneous and Divalproex Delayed Release Tablets
Determining the interaction of Burosumab-twza Subcutaneous and Divalproex Delayed Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: divalproex sodium
Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon
Synonyms: Divalproex sodium, Divalproex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Divalproex Extended Release
- Burosumab-twza Subcutaneous-Divalproex Long-Acting Tablets
- Burosumab-twza Subcutaneous-Divalproex sodium
- Burosumab-twza Subcutaneous-Divalproex Sprinkle
- Burosumab-twza Subcutaneous-Divalproex Sprinkle Capsules
- Burosumab-twza Subcutaneous-Divigel
- Divalproex Delayed Release Tablets-Buspar
- Divalproex Delayed Release Tablets-Buspar Dividose
- Divalproex Delayed Release Tablets-Buspirone
- Divalproex Delayed Release Tablets-Buspirone Hydrochloride
- Divalproex Delayed Release Tablets-Busulfan
- Divalproex Delayed Release Tablets-Busulfan Concentrate Injection